Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 53.16

-0.7%

1:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DewDiligence_on_SI who wrote (16905)	5/23/2005 1:11:49 PM
From: NeuroInvestment	Read Replies (2) of 52153

From a clinical point of view: Compared to a day when a male patient drinks so heavily that they are deadly if they drive, cannot function at work, sleep (at best) when home or (at worst) are assaultive/abusive to their spouses and children: four drinks a day is indeed a non-heavy day. While it would provide a level of function not to our taste, it would be a considerable improvement for them and their families. I am not yet convinced that Vivitrex is going to be a big moneymaker (though I don't claim to have followed it closely at all), but that doubt is based more on reimbursement hassles and the general lack of treatment compliance seen with this population. The fact is that most psychiatric drugs provide improvement--for most patients--up to a level of function that most of us would still consider subpar. Those increments can mean a lot to the patients and their significant others. Harry NeuroInvestment

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next